Why the study?
Does quinidine safely and effectively treat arrhythmias such as intermittent atrial fibrillation and sustained ventricular tachycardia?
Does quinidine safely and effectively treat arrhythmias such as intermittent atrial fibrillation and sustained ventricular tachycardia?
While effective for certain arrhythmias, quinidine must be administered with caution in appropriately selected patients due to the risk of severe proarrhythmic complications.
Answers are grounded in this paper and cite their sources.
Requires vigilant monitoring for proarrhythmia in selected patients; leaves open comparative efficacy versus modern agents.
Although quinidine, the oldest class I antiarrhythmic drug, has been available for several decades, recent reports have emphasized the possibility of dangerous side effects. Quinidine often successfully maintains sinus rhythm in patients with intermittent atrial fibrillation, suppresses sustained ventricular tachycardia in some patients, and minimally depresses left ventricular function. However, it can cause nonfatal and, occasionally, even fatal proarrhythmic complications. Therefore, it must be administered with caution in appropriately selected patients.
No takes yet. Share an insight, caveat, or question.
David M. Salerno (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: